Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community
Yahoo
Friday, November 14, 2014 - 9:29am
tags:
physicians, Allergan, M&A, Valeant Pharmaceuticals
Valeant Should Drop Allergan Bid And Go For Zoetis
Seeking Alpha
Friday, November 14, 2014 - 8:43am
tags:
Valeant Pharmaceuticals, Allergan, Zoetis, M&A
Can Actavis Break The Siege Of Allergan?
Forbes
Friday, November 14, 2014 - 8:27am
tags:
Actavis, Allergan, Valeant Pharmaceuticals, M&A
Are drug developers over-relying on genomics?
Fierce Biotech
Friday, November 14, 2014 - 8:00am
tags:
R&D, genomics
Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland
Yahoo
Friday, November 14, 2014 - 7:57am
tags:
Bristol-Myers Squibb, drug manufacturing
Vascular Solutions and CEO indicted on charges of conspiracy and selling an unapproved device
Bizjournals.com
Thursday, November 13, 2014 - 7:21pm
tags:
Vascular Solutions, conspiracy, devices, off-label
Veracyte misses 3Q net income and revenue expectations
Yahoo/AP
Thursday, November 13, 2014 - 7:17pm
tags:
Veracyte, earnings
Puma Biotech says cancer drug fails mid-stage study
Yahoo/Reuters
Thursday, November 13, 2014 - 7:16pm
tags:
Puma Biotechnology, breast cancer, neratinib
Geron sells last drug in pipeline to J&J unit
Yahoo/Reuters
Thursday, November 13, 2014 - 7:14pm
tags:
Geron, JNJ, imetelstat, Jakafi, myelofibrosis
Boston Scientific Risked Mesh Patient Safety, Jury Told
Bloomberg
Thursday, November 13, 2014 - 7:13pm
tags:
Boston Scientific, earnings, pelvic mesh
Valeant wins over docs with trips, fees
Medical Marketing and Media
Thursday, November 13, 2014 - 4:06pm
tags:
Valeant Pharmaceuticals, physicians
Sanofi execs prep their pitch on a post-Viehbacher R&D strategy
Fierce Biotech
Thursday, November 13, 2014 - 12:59pm
tags:
Sanofi, R&D
Servier Joins Hands With Intarcia Therapeutics To Develop Implantable Diabetic Pump
Bidness Etc.
Thursday, November 13, 2014 - 12:56pm
tags:
Servier, Intarcia, diabetes, devices
Pfizer, Gates Foundation, expand contraceptive access in poor nations
Yahoo/Reuters
Thursday, November 13, 2014 - 12:29pm
tags:
Pfizer, Bill Gates, contraceptives
Mallinckrodt ADHD Drug Hits FDA Trouble; Stock Drops
Investors.com
Thursday, November 13, 2014 - 12:04pm
tags:
Mallinckrodt, ADHD, FDA, methylphenidate ER, Concerta
Humira is in the crosshairs as Amgen gets its first Phase III biosimilars win
Reuters
Thursday, November 13, 2014 - 11:29am
tags:
Humira, Amgen, biosimilars
FDA clears label expansion for Janssen antipsychotic
Seeking Alpha
Thursday, November 13, 2014 - 11:04am
tags:
FDA, JNJ, Janssen, antipsychotics
Under siege by Biogen's new long-acting Eloctate, Baxter's Advate stands its ground
Fierce Pharma Marketing
Thursday, November 13, 2014 - 11:02am
tags:
Biogen Idec, Elocate, Baxter International, Advate
A Day Of Reckoning Approaches For Merck And Its Critics
Forbes
Thursday, November 13, 2014 - 10:29am
tags:
Merck, Zetia, Vytorin
Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue?
Yahoo/Zacks.com
Thursday, November 13, 2014 - 10:27am
tags:
Arena Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.